Cancer Chemotherapy Using Suicide Genes

This publication has 93 references indexed in Scilit:

• Adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy leads to systemic activity against spontaneous and induced metastasis in an orthotopic mouse model of prostate cancer
  International Journal of Cancer, 1997
• Long-Term Survival in a Rodent Model of Disseminated Brain Tumors by Combined Intrathecal Delivery of Herpes Vectors and Ganciclovir Treatment
  Human Gene Therapy, 1996
• Prostate Cancer Gene Therapy: Herpes Simplex Virus Thymidine Kinase Gene Transduction Followed by Ganciclovir in Mouse and Human Prostate Cancer Models
  Human Gene Therapy, 1996
• Expression of the bacterial nitroreductase enzyme in mammalian cells renders them selectively sensitive to killing by the prodrug CB1954
  European Journal Of Cancer, 1995
• Effect of Herpes Simplex Virus Thymidine Kinase Expression Levels on Ganciclovir-Mediated Cytotoxicity and the “Bystander Effect”
  Human Gene Therapy, 1995
• Site-Directed Mutagenesis of Herpes Simplex Virus Type 1 Thymidine Kinase Opposes the Importance of Amino Acid Position 251, 321 and 348 for Selective Recognition of Substrate Analogs
  Biochemical and Biophysical Research Communications, 1995
• In situ delivery of suicide genes for cancer treatment
  European Journal Of Cancer, 1994
• Cancer escape from immune surveillance: How can it be overcome by gene transfer?
  European Journal Of Cancer, 1994
• Replicating vectors for gene therapy of cancer: risks, limitations and prospects
  European Journal Of Cancer, 1994
• Lymphoma Regression Induced by Ganciclovir in Mice Bearing a Herpes Thymidine Kinase Transgene
  Human Gene Therapy, 1990